BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22929180)

  • 1. Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope.
    Johnstone C; Ramos M; García-Barreno B; López D; Melero JA; Del Val M
    Immunol Cell Biol; 2012 Nov; 90(10):978-82. PubMed ID: 22929180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.
    Johnstone C; Guil S; Rico MA; García-Barreno B; López D; Melero JA; Del Val M
    J Gen Virol; 2008 Sep; 89(Pt 9):2194-2203. PubMed ID: 18753229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes.
    Shen X; Wong SB; Buck CB; Zhang J; Siliciano RF
    J Immunol; 2002 Oct; 169(8):4222-9. PubMed ID: 12370352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein.
    Brandenburg AH; de Waal L; Timmerman HH; Hoogerhout P; de Swart RL; Osterhaus AD
    J Virol; 2000 Nov; 74(21):10240-4. PubMed ID: 11024156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
    An LL; Whitton JL
    J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
    Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
    J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.
    Rutigliano JA; Rock MT; Johnson AK; Crowe JE; Graham BS
    Virology; 2005 Jul; 337(2):335-43. PubMed ID: 15916793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of a single viral epitope on T cell response and disease after infection of mice with respiratory syncytial virus.
    Vallbracht S; Jessen B; Mrusek S; Enders A; Collins PL; Ehl S; Krempl CD
    J Immunol; 2007 Dec; 179(12):8264-73. PubMed ID: 18056370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus.
    Johnstone C; de León P; Medina F; Melero JA; García-Barreno B; Val MD
    J Gen Virol; 2004 Nov; 85(Pt 11):3229-3238. PubMed ID: 15483236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.
    Thomson SA; Burrows SR; Misko IS; Moss DJ; Coupar BE; Khanna R
    J Virol; 1998 Mar; 72(3):2246-52. PubMed ID: 9499082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
    Carbonetti NH; Tuskan RG; Lewis GK
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):819-27. PubMed ID: 11429123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
    Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
    J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of DsbA to the N-terminus of CTL chimeric epitope, F/M2:81-95, of respiratory syncytial virus prolongs protein- and virus-specific CTL responses in Balb/c mice.
    Fan CF; Zeng RH; Sun CY; Mei XG; Wang YF; Liu Y
    Vaccine; 2005 Apr; 23(22):2869-75. PubMed ID: 15780735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.
    Openshaw PJ; Anderson K; Wertz GW; Askonas BA
    J Virol; 1990 Apr; 64(4):1683-9. PubMed ID: 2319650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway.
    Neumeister C; Nanan R; Cornu TI; Lüder CGK; Ter Meulen V; Naim H; Niewiesk S
    J Gen Virol; 2001 Feb; 82(Pt 2):441-447. PubMed ID: 11161284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection.
    Jessen B; Faller S; Krempl CD; Ehl S
    J Virol; 2011 Oct; 85(19):10135-43. PubMed ID: 21795345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.
    Lee S; Miller SA; Wright DW; Rock MT; Crowe JE
    J Virol; 2007 Mar; 81(5):2349-58. PubMed ID: 17182672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope.
    Zeng RH; Gong W; Fan CF; Wang YF; Mei XG
    Vaccine; 2006 Feb; 24(7):941-7. PubMed ID: 16159685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
    Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.